{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:41:50Z","timestamp":1787010110505,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1097\/md.0000000000000076","type":"journal-article","created":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T09:08:16Z","timestamp":1410426496000},"page":"e76","source":"Crossref","is-referenced-by-count":26,"title":["Survival in COPD"],"prefix":"10.1097","volume":"93","author":[{"given":"Massimo","family":"Miniati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Pavlickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bottai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20210226","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(07)61380-4","article-title":"Global burden of COPD: risk factors, prevalence, and future trends.","volume":"370","author":"Mannino","year":"2007","journal-title":"Lancet"},{"key":"R3-5-20210226","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1183\/09031936.00012408","article-title":"Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.","volume":"32","author":"Mannino","year":"2008","journal-title":"Eur Respir J"},{"key":"R4-5-20210226","doi-asserted-by":"crossref","first-page":"e37483","DOI":"10.1371\/journal.pone.0037483","article-title":"Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.","volume":"7","author":"Agusti","year":"2012","journal-title":"PLoS ONE"},{"key":"R5-5-20210226","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.201201-0034OC","article-title":"Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.","volume":"186","author":"Divo","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-5-20210226","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201207-1299OC","article-title":"Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification. A study of the general population.","volume":"186","author":"Lange","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-5-20210226","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1164\/rccm.201206-1113OC","article-title":"Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.","volume":"186","author":"Thomsen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-5-20210226","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1164\/rccm.201209-1665OC","article-title":"Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.","volume":"187","author":"Vanfleteren","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-5-20210226","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.20275","article-title":"Cryptic haplotypes of SERPIN A1 confer susceptibility to chronic obstructive pulmonary disease.","volume":"27","author":"Chappell","year":"2006","journal-title":"Hum Mutat"},{"key":"R10-5-20210226","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A self-complete measure of heath status for chronic airflow limitation. The St. Georges respiratory questionnaire.","volume":"145","author":"Jones","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"R11-5-20210226","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry.","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"R12-5-20210226","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1183\/09031936.05.00034905","article-title":"Standardisation of the single-breath determination of carbon monoxide uptake in the lung.","volume":"26","author":"MacIntyre","year":"2005","journal-title":"Eur Respir J"},{"key":"R13-5-20210226","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2214\/ajr.163.5.7976869","article-title":"Emphysema: definition, imaging, and quantification.","volume":"163","author":"Thurlbeck","year":"1994","journal-title":"Am J Roentgenol"},{"key":"R14-5-20210226","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1465-9921-12-37","article-title":"Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.","volume":"12","author":"Miniati","year":"2011","journal-title":"Respir Res"},{"key":"R15-5-20210226","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/bimj.200900310","article-title":"Laplace regression with censored data.","volume":"52","author":"Bottai","year":"2010","journal-title":"Biometrical J"},{"key":"R16-5-20210226","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazard of hazard ratios.","volume":"21","author":"Hernan","year":"2010","journal-title":"Epidemiology"},{"key":"R17-5-20210226","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1183\/09031936.00111707","article-title":"; ECLIPSE Investigators. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE).","volume":"31","author":"Vestbo","year":"2008","journal-title":"Eur Respir J"},{"key":"R18-5-20210226","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1164\/rccm.201205-0906ED","article-title":"COPD and the solar system. Introducing the chronic obstructive pulmonary disease comorbidome.","volume":"186","author":"Fabbri","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R19-5-20210226","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2796.2008.01975.x","article-title":"ECHOS Lung Function Study Group. Chronic obstructive pulmonary disease in patients admitted with heart failure.","volume":"264","author":"Iversen","year":"2008","journal-title":"J Intern Med"},{"key":"R20-5-20210226","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/eurjhf\/hfq050","article-title":"ECHOS Lung Function Study Group. The prognostic importance of lung function in patients admitted with heart failure.","volume":"2","author":"Iversen","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"R21-5-20210226","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.201209-1722OC","article-title":"Mortality by level of emphysema and airway wall thickness.","volume":"187","author":"Johannessen","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-5-20210226","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1183\/09031936.00146012","article-title":"Lung function indices for predicting mortality in COPD.","volume":"42","author":"Boutou","year":"2013","journal-title":"Eur Respir J"},{"key":"R23-5-20210226","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1164\/ajrccm.187.3.328b","article-title":"Look at comorbidities, but dont forget lung function.","volume":"187","author":"Cerveri","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-5-20210226","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/MCP.0000000000000027","article-title":"Nonadherence in chronic obstructive pulmonary disease patients: what do we know and what should be done next.","volume":"20","author":"Bender","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"R25-5-20210226","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thx.2009.113662","article-title":"Adherence to inhaled therapy, mortality and hospital admission in COPD.","volume":"64","author":"Vestbo","year":"2009","journal-title":"Thorax"},{"key":"R26-5-20210226","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.ijcard.2013.01.170","article-title":"Forced expiratory volume in one second: prognostic value in systolic heart failure.","volume":"168","author":"Miniati","year":"2013","journal-title":"Int J Cardiol"},{"key":"R27-5-20210226","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2466-13-69","article-title":"Prognostic value of alveolar volume in systolic heart failure: a prospective observational study.","volume":"13","author":"Miniati","year":"2013","journal-title":"BMC Pulm Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:37:14Z","timestamp":1620945434000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201409020-00005"}},"subtitle":["Impact of Lung Dysfunction and Comorbidities"],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000076","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}